中国循证医学杂志2024,Vol.24Issue(1) :91-97.DOI:10.7507/1672-2531.202305121

卫生经济学证据在临床实践指南制订中的应用

The role of health economic evidence in the development of clinical practice guidelines

郭文昊 李严 王思月 胡冰琪 李洪超
中国循证医学杂志2024,Vol.24Issue(1) :91-97.DOI:10.7507/1672-2531.202305121

卫生经济学证据在临床实践指南制订中的应用

The role of health economic evidence in the development of clinical practice guidelines

郭文昊 1李严 1王思月 1胡冰琪 1李洪超1
扫码查看

作者信息

  • 1. 中国药科大学国际医药商学院(南京 211198);中国药科大学药物经济学评价研究中心(南京 211198)
  • 折叠

摘要

本文旨在探讨卫生经济学证据在临床实践指南制订和证据推荐中的应用情况,并为临床诊疗决策提供参考依据.通过梳理国内外临床实践指南中卫生经济学证据的使用情况,总结临床实践指南制订和证据推荐过程中应用卫生经济学证据的难点.目前各国临床实践指南中卫生经济学证据的使用情况存在明显差异,且受到临床实践指南目标与卫生经济学证据自身限制等困难的影响,缺乏规范的方法学指导,导致卫生经济学证据在临床实践指南中尚未得到广泛应用.因此,需要进一步研究优化卫生经济学与临床实践指南结合,并制定规范的方法学指导.

Abstract

This article aims to explore the application of health economics evidence in the development of clinical practice guidelines and evidence recommendations,and to provide better references for clinical decision-making.By reviewing the use of health economics evidence in domestic and international clinical practice guidelines,the difficulties in the application of health economics evidence in the development of clinical practice guidelines and evidence recommendations were summarized.It was found that there were significant differences in the use of health economics evidence in clinical practice guidelines in different countries,and these differences were affected by the goals of clinical practice guidelines and limitations of health economics evidence itself,lacking standardized methodological guidance,resulting in limited use of health economics evidence in clinical practice guidelines.Therefore,further research is needed to optimize the integration of health economics and clinical practice guidelines,and develop standardized methodological guidance.

关键词

卫生经济学证据/临床实践指南/卫生经济评价

Key words

Health economic evidence/Clinical practice guideline/Health economic evaluation

引用本文复制引用

出版年

2024
中国循证医学杂志
四川大学

中国循证医学杂志

CSTPCDCSCD北大核心
影响因子:1.761
ISSN:1672-2531
参考文献量9
段落导航相关论文